Whether Avastin (bevacizumab) helps women with breast cancer is still under debate. Breast cancer expert, Harold Burstein, MD, PhD, of the Dana-Farber Cancer Institute, explains how Avastin works in cancer and why it is so controversial in breast cancer in this video from the National Comprehensive Cancer Network (NCCN). The NCCN is a not-for-profit alliance of 21 leading cancer centers—including Dana-Farber Cancer Institute—dedicated to improving care for cancer patients. For more information on breast cancer treatments, including the NCCN Guidelines for Patients, or to find an NCCN cancer center near you, visit www.NCCN.com.
Link to this comment:
All Comments (0)